MedTrace Logo

Clinical Study of PTFE Covered Stent for Treating Portal Hypertension

NCT06117735 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 177

Last updated 2024-03-12

No results posted yet for this study

Summary

To validate the safety and efficacy of TIPS (Transjugular Intrahepatic Portosystemic Shunt) using PTFE covered stent in the treatment of portal hypertension.

Conditions

  • Portal Hypertension

Interventions

DEVICE

Transjugular Intrahepatic Portosystemic shunt

The experimental device is a class III implanted shunt device, which will be used to create a shunt between intrahepatic and portosystemic to reduce portal hypertension.

Sponsors & Collaborators

  • Enlight Medical Technologies (Shanghai) Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Bin Xiong · The First Affiliated Hospital of Guangzhou Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2025-12-30
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06117735 on ClinicalTrials.gov